Gregory Kafaf

Observer
DISC Type : ci

Director Market Access Alternative Models at Novo Nordisk

New York City Metropolitan Area, United States

Overview

Gregory Kafaf is a strategic business leader at Novo Nordisk, specializing in driving commercial strategy and market access innovation in complex healthcare settings. With an MBA from Cornell, he has a track record of developing enterprise growth strategies and optimizing portfolio investments.

Outside of his direct professional role, Gregory has shown an interest in the consulting world, following firms like Accenture and Deloitte. His education at Colgate University suggests a foundation in liberal arts before his specialization in business and healthcare strategy.

He holds a Six Sigma Green Belt certification, highlighting a commitment to process improvement and operational excellence.

Personality Overview

Value Driven

Curious

Example Seeker

They often ask many questions and rely heavily on information and documentation.  They are generally good communicators and can be hard to convince. They can sound friendly and charming but can quickly change gears to become inquisitive and probing.

Topics They Care About

Healthcare Market Access
Leads initiatives at Novo Nordisk to develop alternative models for patient care, focusing on telehealth, retail pharmacy, and direct-to-patient channels.
Enterprise Growth Strategy
Directs long-range planning, portfolio investment decisions, and commercial growth strategies for Novo Nordisk's US business.
Digital Transformation
Previously led strategic projects in digital transformation and business model innovation at PVH Corp. , focusing on digitizing planning, design, and consumer engagement.

Media Appearances

Gregory has no verified media appearances

Work History

6-2025
Director Market Access Alternative Models at Novo Nordisk
12-2023 - 7-2025
Director Enterprise Strategy at Novo Nordisk
1-2022 - 12-2023
Associate Director - Enterprise Strategy at Novo Nordisk
7-2020 - 1-2022
Strategy & Business Consulting at Bayer
5-2019 - 7-2020
Senior Manager - Value Chain Strategies at PVH Corp.

Education

2018 - 2020
Master of Business Administration - MBA from Cornell Johnson Graduate School of Management
2008 - 2012
Political Science from Colgate University

More Information

Social Presence :

Prographics :

Exp : 8 Location : New York City Metropolitan Area, United States Job Level : Mid-senior Designation : Director Market Access Alternative Models at Novo Nordisk
URL has been copied!

Insights For Selling To Gregory

During A Call Or A Meeting

DO's

  • Help them realize that there is no personal risk in making this decision
  • Use phrases like ‘clear proof that’, ‘data shows’ etc.
  • Focus on immediate action-items rather than the larger goals

DONT's

  • Don’t be too objective but make sure to pad your storytelling with data points
  • Avoid making offhand commitments
  • Don’t rely excessively on your relationship with them to win the deal

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Gregory is

  • Clear proof of product value matters to them, followed by others' testimonials and rapport.
  • Will you ever get a clear answer from Gregory

  • They are practical and friendly, don't expect a clear-cut response often.

Insights For Deal Planning

    How fast (or slow) will Gregory move?

  • They like to perform full analysis and can take time to make any decision.
  • Can Gregory take some risk or not?

  • They systematically evaluate all decisions and are unlikely to take many risks.

You And Gregory

Personality Compatibility


Other Novo Nordisk Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.